High-frequency and low-frequency chest compression: effects on lung water secretion, mucus transport, heart rate, and blood pressure using a trapezoidal source pressure waveform.

High-frequency chest compression (HFCC), using an appropriate source (pump) waveform for frequencies at or above 3 Hz, can enhance pulmonary clearance for patients with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Using a trapezoidal HFCC source pressure waveform, secretion of water from epithelial tissue and transport of mucus through lung airways can be enhanced for patients with CF and COPD. At frequencies below 3 Hz, low-frequency chest compression (LFCC) appears to have a significant impact on the cardiovascular system.

A simulation tool to study high-frequency chest compression energy transfer mechanisms and waveforms for pulmonary disease applications.

High-frequency chest compression (HFCC) can be used as a therapeutic intervention to assist in the transport and clearance of mucus and enhance water secretion for cystic fibrosis patients. An HFCC pump-vest and half chest-lung simulation, with 23 lung generations, has been developed using inertance, compliance, viscous friction relationships, and Newton's second law. The simulation has proven to be useful in studying the effects of parameter variations and nonlinear effects on HFCC system performance and pulmonary system response.

Induced respiratory system modeling by high frequency chest compression using lumped system identification method.

High frequency chest compression (HFCC) treatment systems are used to promote mucus transport and mitigate pulmonary system clearance problems to remove sputum from the airways in patients with Cystic Fibrosis (CF) and at risk of developing chronic obstructive pulmonary disease (COPD). Every HFCC system consists of a pump generator, one or two hoses connected to a vest, to deliver the pulsation. There are three different waveforms in use; symmetric sine, the asymmetric sine and the trapezoid waveforms.

Detecting changes in respiratory patterns in high frequency chest compression therapy by single-channel blind source separation.

High Frequency Chest Compression (HFCC) is used as a method to remove the mucus in the airway for Cystic Fibrosis (CF) patients. As the characteristics of the tracheal sound reflect the conditions of airways, in this paper, we propose a novel method to evaluate the respiratory patterns in HFCC therapy by using single channel tracheal sounds only. The difficulty of analyzing tracheal sounds lies in that it has a wider frequency band than the air flow at the mouth, and is always corrupted by other biomedical signals and noises.

Free-knot spline model for analysis of pulmonary function.

The pulmonary function test (PFT) is used to evaluate and monitor respiratory function. The PFT is critical for the care of patients having cystic fibrosis (CF) and adjusting their clinical treatments. We analyzed the percent predicted value of forced expiratory volume in one second (FEV(1)%) from PFT of CF patients collected four times a year from 1966.